Session: Hereditary cancer in high-risk men

Speakers: Kelly Metcalfe, RN, PhD and Tuya Pal, MD

This 90-minute concurrent session will focus on medical recommendations and psychosocial support needs for men who carry a BRCA mutation.
Drs. Metcalfe and Pal will address:

• emerging data on prognosis and treatment specific to BRCA-associated prostate cancer
• emerging information and clinical trials looking at cancer risks in male BRCA carriers and risk-management options
• current risk-management recommendations for men with BRCA mutations
• the lifetime and age-specific cancer risks for men with BRCA 1 and BRCA 2
• psychosocial needs of men with mutation
• behavioral and emotional outcomes for men who have undergone genetic testing
• reasons why men might or might not want to know their BRCA mutation status
• unique challenges for men in discussing cancer risk and information with family members
  

This session is appropriate for:

• men who carry a BRCA mutation
• parents/relatives/loved ones of men who carry a BRCA mutation
• patient advocates, support group facilitators, and people who work with men
  with a BRCA mutation
• health care providers who provide care to people with BRCA mutations
• social workers/mental health care professionals who treat people with BRCA mutations

Close Window